FI902143A0 - Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar. - Google Patents

Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar.

Info

Publication number
FI902143A0
FI902143A0 FI902143A FI902143A FI902143A0 FI 902143 A0 FI902143 A0 FI 902143A0 FI 902143 A FI902143 A FI 902143A FI 902143 A FI902143 A FI 902143A FI 902143 A0 FI902143 A0 FI 902143A0
Authority
FI
Finland
Prior art keywords
hiv
pct
antigen
artificial
immunobestaemningsfoerpackningar
Prior art date
Application number
FI902143A
Other languages
English (en)
Inventor
Jerzy Trojnar
Britta Wahren
Ulla Ruden
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20370026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI902143(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Ab filed Critical Ferring Ab
Publication of FI902143A0 publication Critical patent/FI902143A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI902143A 1987-10-28 1990-04-27 Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar. FI902143A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8704185A SE8704185L (sv) 1987-10-28 1987-10-28 Nya peptider, artificiella antigener och immunoanalystestsatser
PCT/SE1988/000570 WO1989003844A1 (en) 1987-10-28 1988-10-27 Hiv peptides, artificial hiv antigens and immunoassay kits

Publications (1)

Publication Number Publication Date
FI902143A0 true FI902143A0 (fi) 1990-04-27

Family

ID=20370026

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902143A FI902143A0 (fi) 1987-10-28 1990-04-27 Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar.

Country Status (11)

Country Link
US (1) US5981170A (fi)
EP (1) EP0396559B1 (fi)
JP (2) JP2818797B2 (fi)
AT (1) ATE141286T1 (fi)
DE (1) DE3855479T2 (fi)
DK (1) DK104590A (fi)
FI (1) FI902143A0 (fi)
IL (1) IL88224A0 (fi)
NO (1) NO302369B1 (fi)
SE (1) SE8704185L (fi)
WO (1) WO1989003844A1 (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
DE69129207T2 (de) * 1990-01-16 1998-10-08 Orgenics Ltd Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
AU7676891A (en) * 1990-04-03 1991-10-30 Genentech Inc. Hiv envelope polypeptides
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
US6277824B1 (en) 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
WO2000029008A2 (en) 1998-11-16 2000-05-25 Board Of Regents, The University Of Texas System Hiv-specific t-cell induction
US7094757B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Complexes comprising a prion protein and a peptidyl prolyl isomerase chaperone, and method for producing and using them
US6962982B2 (en) 2001-06-22 2005-11-08 Roche Diagnostics Corporation Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
US7094884B2 (en) 2001-06-22 2006-08-22 Roche Diagnostics Corporation Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
DK1402015T3 (da) 2001-06-22 2011-12-05 Hoffmann La Roche Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein og FkpA eller SlyD
US7615530B2 (en) * 2003-08-29 2009-11-10 Artificial Cell Technologies, Inc. Immunogenic compositions and methods of use
JPWO2005040799A1 (ja) * 2003-10-29 2007-04-19 岡田 秀親 相補性ペプチド人工抗体
WO2007050569A2 (en) 2005-10-25 2007-05-03 Donald Templeton Haynie Polypeptide multilayer films and methods
US7723294B2 (en) * 2007-04-02 2010-05-25 Artificial Cell Technologies, Inc. Polypeptide films and methods
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
PT2691530T (pt) 2011-06-10 2018-05-10 Univ Oregon Health & Science Glicoproteínas e vectores recombinantes cmv
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
ATE116006T1 (de) * 1985-04-29 1995-01-15 Genetic Systems Corp Synthetische antigene zum nachweis von aids.
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4735896A (en) * 1986-03-04 1988-04-05 United Biomedical, Inc. Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
WO1987006005A1 (en) * 1986-03-24 1987-10-08 Ortho Pharmaceutical Corporation Synthetic htlv-iii peptides, compositions and uses thereof
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4957737A (en) * 1986-05-27 1990-09-18 Hoffmann-La Roche Inc. HTLV-III (LAV) envelope peptides
DE3789633T2 (de) * 1986-05-27 1994-08-04 Hoffmann La Roche HTLV-III(LAV)Decke-Peptide.
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
DE3901857A1 (de) * 1989-01-23 1990-07-26 Boehringer Mannheim Gmbh Verfahren zur bestimmung von hiv 2 antikoerpern

Also Published As

Publication number Publication date
DK104590D0 (da) 1990-04-27
US5981170A (en) 1999-11-09
DE3855479D1 (de) 1996-09-19
NO901899D0 (no) 1990-04-27
DE3855479T2 (de) 1997-01-02
JP3231666B2 (ja) 2001-11-26
ATE141286T1 (de) 1996-08-15
NO901899L (no) 1990-04-27
NO302369B1 (no) 1998-02-23
JPH10101697A (ja) 1998-04-21
DK104590A (da) 1990-06-26
SE8704185D0 (sv) 1987-10-28
IL88224A0 (en) 1989-06-30
EP0396559B1 (en) 1996-08-14
WO1989003844A1 (en) 1989-05-05
EP0396559A1 (en) 1990-11-14
SE8704185L (sv) 1989-04-29
JP2818797B2 (ja) 1998-10-30
JPH03500648A (ja) 1991-02-14

Similar Documents

Publication Publication Date Title
FI902143A0 (fi) Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar.
ATE114672T1 (de) Peptidzusammensetzung und verfahren zum nachweis von antikörpern gegen htlv-iii.
ES8801839A1 (es) Procedimiento para detectar anticuerpos a htlv-iii y diagnosticar aids, arc o estados pre-aids
EA200100943A1 (ru) Вич-пептиды, антигены, вакцинные композиции, набор для иммуноанализа и способ определения вич-индуцированных антител
FI84107C (fi) HbA1c:s immunologiska bestaemningsfoerfarande som innefattar denaturering
DE69027812D1 (de) Verfahren zur Zurichtung eines verbesserten Western-Blott-Immuntestverfahrens
DE68923882D1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
Child et al. A review of the applications of immunochemistry to archaeological bone
DE69738770D1 (de) Porphyromonas gingivalis Antigene zur Diagnose und Behandlung von Periodontitis
KR920702688A (ko) Htlv-1 감염의 진단, 치료 및 왁찐 접종용 펩타이드 및 그것으로 부터 유도된 항체
KR900004935A (ko) 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
DE69015708D1 (de) Künstliche peptid-zusammensetzungen mit immunoreaktiven antikörpern von htlv-1.
DK0383599T3 (da) Protein-anticancermiddel
FI913714A (fi) Peptider med foer a 1-mikroglobulin karakteristiska antigeniska determinanter.
ATE137864T1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
KR910007962A (ko) Hiv 관련 펩티드
NO914725D0 (no) Cystein-tiolbeskyttede peptider for bruk ved immunologiske maalinger
ATE80895T1 (de) Bordetella pertussis-polypeptide und toxinantigene.
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
TH62264A (th) Hiv เพพไทด์, แอนติเจน องค์ประกอบวัคซีน, ชุดสำเร็จรูปอิมมูโนแอสเสย์ และวิธีสำหรับตรวจหาแอนติบอดีที่ชักนำโดย hiv

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: FERRING AB